Bio Protocol vs MVL — how do they compare? Bio Protocol trades at Rp513.43 (market cap Rp1,15T, Rp256,3M 24h volume), while MVL trades at Rp16.38 (market cap Rp472,56M, Rp1,47M 24h volume). The key difference: Bio Protocol is far larger — about 2433.6× MVL's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 27,8B / 30B MVL (93%) for MVL. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and MVL for 52 Days on average.
| BIO | MVL | |
|---|---|---|
Market Cap | Rp1,15T | Rp472,56M |
Volume (24h) | Rp256,3M | Rp1,47M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 27,8B / 30B MVL (93%) |
Typical Hold Time | 16 Days | 52 Days |
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →MVL, which stands for Mobility Value Lab, is an innovative project that combines the fields of mobility and blockchain technology. The primary goal of MVL is to share data value among all participants in its ecosystem. This integration is accomplished using various blockchain protocols that are designed to enhance the development of mobility services.
Read more on MVL →